Abstract
The mechanism of the blocking action of phenylcyclohexyl derivative IEM-1925 on ionotropic NMDA and AMPA glutamate receptors was studied. Experiments on isolated rat brain neurons (hippocampal pyramidal cells and striatal cholinergic interneurons) were performed using local voltage clamping in the “whole cell” configuration. In equilibrium conditions at a membrane potential of −80 mV, there was no selectivity in the action of IEM-1925 on the open channels of either type of glutamate receptor. However, data were obtained showing significant differences in the mechanisms of the blocking actions. Although IEM-1925 was unable to penetrate into closed channels of either receptor type, molecules were able to leave closed AMPA receptor channels but not closed NMDA receptor channels. In hyperpolarization, the departure of the blocker from open NMDA receptor channels was slowed, while departure from open and closed AMPA receptor channels was accelerated. The blocker thus appeared able to penetrate AMPA receptor channels to enter cells, the gating mechanism of these channels being located above the blocker binding site. The actions of IEM-1925 on NMDA and AMPA receptors were compared with its ability to suppress tremor in mice induced with s.c. doses of arecoline. The results indicated that both types of receptors have a role in producing tremor. The differences in the mechanisms of action on AMPA and NMDA receptors may explain the ambiguous nature of the effects of the glutamate channel blocker in experimental therapy.
Similar content being viewed by others
References
N. Ya. Lukomskaya, V. V. Lavrent’eva, L. A. Starshinova, E. P. Zhabko, L. V. Gorbunova, T. B. Tikhonova, V. E. Gmiro, and L. G. Magazanik, “Effects of blockers of ionotropic glutamate receptor channels on the development of pentylenetetrazole kindling in mice,” Ros. Fiziol. Zh. im. I. M. Sechenova, 91, No. 11, 1241–1250 (2005).
N. Ya. Lukomskaya, N. I. Rukoyatkina, L. V. Gorbunova, V. E. Gmiro, K. V. Bol’shakov, and L. G. Magazanik, “Comparison of the anticonvulsive activity of organic mono-and dications and their ability to inhibit NMDA and AMPA glutamate receptors,” Ros. Fiziol. Zh. im. I. M. Sechenova, 88, No. 9, 1161–1171 (2002).
N. Ya. Lukomskaya, N. I. Rukoyatkina, L. V. Gorbunova, V. E. Gmiro, and L. G. Magazanik, “Studies of the roles of NMDA and AMPA glutamate receptors in the mechanism of convulsive syndrome induced in mice by administration of corasol,” Ros. Fiziol. Zh. im. I. M. Sechenova, 89, No. 3, 292–301 (2003).
L. G. Magazanik, “Ion channel blockade as an approach to studying AMPA receptor subtypes,” Ros. Fiziol. Zh. im. I. M. Sechenova, 84, No. 10, 994–1005 (1998).
L. G. Magazanik, K. V. Bol’shakova, S. L. Buldakova, V. E. Gmiro, N. A. Dorofeeva, N. Ya. Lukomskaya, N. N. Potap’eva, M. V. Samoilova, D. B. Tikhonov, I. M. Fedorova, and E. V. Frolova, “Structural characteristics of ionotropic glutamate receptors identified by channel blockade,” Ros. Fiziol. Zh. im. I. M. Sechenova, 86, No. 9, 1138–1151 (2000).
N. I. Rukoyatkina, L. V. Gorbunova, V. E. Gmiro, and N. Ya. Lukomskaya, “The ability of glutamate receptor antagonists to decrease the severity of experimental catalepsy in mice,” Ros. Fiziol. Zh. im. I. M. Sechenova, 86, No. 6, 626–634 (2000).
N. I. Rukoyatkina, L. V. Gorbunova, V. E. Gmiro, and N. Ya. Lukomskaya, “The ability of new non-competitive glutamate receptor blockers to decrease motor impairments in animals,” Ros. Fiziol. Zh. im. I. M. Sechenova, 87, No. 9, 1260–1267 (2001).
T. B. Tikhonova, D. B. Tikhonov, and L. G. Magazanik, “Characteristics of the blockade of NMDA and AMPA glutamate receptor ion channels by dicationic derivatives of phenylcyclohexyl,” Biol. Membrany, 22, No. 4, 290–299 (2005).
K. V. Bolshakov, D. B. Tikhonov, V. E. Gmiro, and L. G. Magazanik, “Different arrangement of hydrophobic and nucleophilic components of channel binding sites in NMDA and AMPA receptor is revealed by channel blockade,” Neurosci. Lett., 291, No. 2, 101–104 (2000).
K. V. Bolshakov, G. E. Gmiro, D. B. Tikhonov, and L. G. Magazanik, “Determinants of trapping block of N-methyl-D-aspartate receptor channels,” J. Neurochem., 87, No. 1, 56–65 (2003).
K. V. Bolshakov, K. H. Kim, N. N. Potapjeva, V. E. Gmiro, D. B. Tikhonov, P. N. R. Usherwood, I. R. Mellor, and L. G. Magazanik, “Design of antagonists for NMDA and AMPA receptors,” Neuropharmacol., 49, 144–155 (2005).
S. L. Buldakova, V. S. Vorobjev, I. N. Sharonova, M. V. Samoilova, and L. G. Magazanik, “Characterization of AMPA receptor populations in rat brain cells by the use of subunit-specific open channel blocking drug, IEM-1460,” Brain Res., 94, No. 1, 261–268 (1999).
N. Burnashev, A. Villarroel, and B. Sakmann, “Dimensions and ion selectivity of recombinant AMPA and kainate receptor channels and their dependence on Q/R site residues,” J. Physiol. (London), 496, 165–173 (1996).
R. Dingledine, K. Borges, D. Bowie, and S. F. Traynelis, “The glutamate receptor ion channels,” Pharmacol. Rev., 51, 7–61 (1999).
S. A. Lipton, “Prospects for clinically tolerated NMDA antagonists: open channel blockers and alternative redox states of nitric oxide,” Trends Neurosci., 16, 527–532 (1993).
L. G. Magazanik, S. L. Buldakova, M. V. Samoilova, V. E. Gmiro, I. R. Mellor, and P. N. R. Usherwood, “Block of open channels of recombinant AMPA receptors and native AMPA/kainate receptors by adamantane derivatives,” J. Physiol. (London), 505, No. 3, 655–663 (1997).
L. Nowak, P. Bregestovski, P. Ascher, A. Herbet, and A. Prochiantz, “Magnesium gates glutamate-activated channels in mouse central neurones,” Nature, 307, 462–465 (1984).
C. G. Parsons, W. Danysz, and G. Quack, “Glutamate in CNS disorders as a target for drug development: an update,” Drug New Perspect., 11, 523–569 (1998).
C. G. Parsons, W. Danysz, and G. Quack, “Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist — a review of preclinical data,” Neuropharmacol., 38, 735–767 (1999).
M. Rogawski, “Therapeutic potential of excitatory amino acid antagonists: channel blockers and 2,3-benzodiazepines,” Trends Pharmacol. Sci., 14, 325–331 (1993).
M. Rogawski, “Low affinity channel blocking (uncompetitive) NMDA receptor antagonists as therapeutic agents-toward an understanding of their favorable tolerability,” Amino Acids, 19, 133–149 (2000).
M. V. Samoilova, S. L. Buldakova, V. S. Vorobjev, I. N. Sharonova, and L. G. Magazanik, “Open channel blocking drug, IEM-1460, reveals functionally distinct α-amino-3-hydroxy-5 methyl-4-isoxazolepropionate receptors in rat brain neurons,” Neurosci., 94, No. 1, 261–268 (1999).
D. B. Tikhonov and L. G. Magazanik, “Voltage dependence of open channel blockade: onset and offset rates,” J. Membr. Biol., 161, No. 1, 1–8 (1998).
D. B. Tikhonov, M. V. Samoilova, S. L. Buldakova, V. E. Gmiro, and L. G. Magazanik, “Voltage-dependent block of native AMPA receptor channels by dicationic compounds,” Britain. J. Pharmacol., 129, No. 2, 265–274 (2000).
A. Villarroel, N. Burnashev, and B. Sakmann, “Dimensions of the narrow portion of a recombinant NMDA receptor channel,” Biophys. J., 68, 866–875 (1996).
V. S. Vorobjev, “Vibrodissociation of sliced mammalian nervous tissue,” J. Neurosci. Meth., 38, 145–150 (1991).
L. P. Wollmuth, T. Kuner, and B. Sakmann, “Intracellular Mg2+ interacts with structural determinants of the narrow constriction contributed by the NR1-subunit in the NMDA receptor channel,” J. Physiol. (London), 506, 33–52 (1998).
A. M. Woodhull, “Ionic blockage of sodium channels in nerve,” J. Gen. Physiol., 61, 687–708 (1973).
E. V. Zeimal and Z. Votava, “Antagonism against the arecoline tremors of oxyphenonium and its tertiary analogue after intravenous and intracerebral administration in mice,” Experientia, 15, No. 17, 471–472 (1961).
Author information
Authors and Affiliations
Additional information
__________
Translated from Rossiiskii Fiziologicheskii Zhurnal imeni I. M. Sechenova, Vol. 92, No. 1, pp. 27–38, January, 2006.
Rights and permissions
About this article
Cite this article
Magazanik, L.G., Tikhonov, D.B., Tikhonova, T.B. et al. Mechanisms of the blockade of glutamate channel receptors: Significance for structural and physiological investigations. Neurosci Behav Physiol 37, 277–284 (2007). https://doi.org/10.1007/s11055-007-0012-9
Received:
Issue Date:
DOI: https://doi.org/10.1007/s11055-007-0012-9